Cover image of PharmaTalkRadio
(11)
Science

PharmaTalkRadio

Updated 9 days ago

Science
Read more

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

Read more

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

iTunes Ratings

11 Ratings
Average Ratings
8
3
0
0
0

iTunes Ratings

11 Ratings
Average Ratings
8
3
0
0
0
Cover image of PharmaTalkRadio

PharmaTalkRadio

Latest release on Mar 10, 2020

Read more

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

Rank #1: Immuno-Oncology 360°: Business Models for Complex Science by Dr Axel Hoos of GSK

Podcast cover
Read more
Originally presented during the business aspects plenary session at Immuno-Oncology 360° 2017, Dr Axel Hoos of GSK discusses business models for complex science. 

Save the date for the 4th annual IO360° conference, taking place February 7-9, 2018 in New York City. Dr Hoos returns as lead advisor, as well as moderating a talk called, "Investor Roundtable: The Role of IO within Large Pharma - Where Does it Stand?" with panelists from Citi, Atlas Venture, New Enterprise Associates, and SR One Ltd.

Jun 21 2017

25mins

Play

Rank #2: Keytruda in Combo with Chemo in NSCLC

Podcast cover
Read more
Originally recorded at the 4th annual Immuno-Oncology 360° 2018 event, Dr Corey Langer, Director, Thoracic Oncology and Professor of Medicine for the Perelman Center for Advanced Medicine at the University of Pennsylvania, discusses data on Keytruda in combination with chemotherapy in non-small cell lung cancer.

This year, the University of Pennsylvania will be represented by Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies. Dr Ruella will be discussing the next steps for CAR-T therapy for cancer on day three during the Next Generation Cell Therapy Plenary

To join in on the discussion at the 5th annual IO360 conference taking place February 6-8, 2019 in New York, NY!

Dec 11 2018

25mins

Play

Rank #3: Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark

Podcast cover
Read more
During his graduate work, Dr Benjamine Liu observed the many bottlenecks that get in the way of clinical trials slowing the development of new treatments for patients. This challenge inspired him to launch Trialspark.

Trialspark partners with doctors to create FDA compliant trial sites within their existing practices (like Airbnb), unlocking the 98% of patients and doctors not involved in trials today and democratizing access to research treatments.  In this podcast discussion with Ben, we discuss how to reimagine clinical trials, entrepreneurism, the rise of Trialspark and reducing the barriers for patients and investigators. 

Ben will be speaking at DPharm on September 26th in Boston with Dr Ulo Palm, SVP Global Drug Development Operations, Allergan on a case study to scale more efficient clinical trials.

For more information about Trialspark, visit www.trialspark.com

For more information about DPharm visit www.theconferenceforum.org

Producer: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm

Aug 17 2018

22mins

Play

Rank #4: CAR-T Therapy: Optimization Through Engineering T-cells or Combinations

Podcast cover
Read more
Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania focuses on the next steps for CAR-T therapy for cancer, discussing the novel approaches that are being developing in Dr Carl June’s lab including CAR-T combinations with small molecules and gene-editing.

Save the date for IO Combinations 360° happening June 20-21, 2019 at the Wyndham Historic District Hotel, Philadelphia, PA and for IO360° happening February 26-28, 2020 at the Crowne Plaza Times Square in New York City.

May 02 2019

20mins

Play

Rank #5: Improving T Cell Therapies via Next Generation Technologies

Podcast cover
Read more
The pipeline of adoptive T-cell therapies and other cell based immuno-oncology programs continues to expand with a number of modifications and improvements to the first generation programs. These platforms include improved spcificty and delivery - including non-viral platforms, targeting of multiple antigens, editing constructs, and a variety of strategies to address toxicity and the tumor microenvironment. This panel of experts, moderated by Dr Gbola Amusa, Chardan and recorded at the 5th annual Immuno-Oncology 360° Summit, will consider the major technical and clinical improvements to cell based IO therapeutics that will lead to more durable therapies and the ability to treat both liquid and solid tumors.

Panelists include:
Dr Robert Ang, Neon TherapeuticsDr Usman "Oz" Azam, TmunityMichael Dombeck, Precision BioSciencesDr Aiman Shalabi, GSK
Save the date for the 6th annual IO360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Oct 17 2019

49mins

Play

Rank #6: Key Trends in Drug Delivery: Expert Perspective

Podcast cover
Read more
Opening talk at Drug Delivery West, 2018

Key Trends in Drug Delivery: Expert Perspective

Randall Mrsny, PhD

Professor's Chair, Department of Pharmacy and Pharmacology,

University of Bath

Jun 23 2018

34mins

Play

Rank #7: Partnering with Patients on Clinical Development Protocols

Podcast cover
Read more
Linda Kollmar, Executive Director, Scientific Medical Patient Perspective - Oncology, Merck, shares with the audience at the 6th annual Patients as Partners US conference, Merck's strategy for bringing on a patient, as an equal stakeholder of their clinical development team, to provide patient input in protocol development and trial design. Ms Kollmar walks the audience through how this was done, the role of the patient employee and the impact it has to date on the clinical development initiatives.

To learn more about the 7th annual Patients as Partners US conference taking place June 29-30, 2020 in Philadelphia, PA please visit theconferenceforum.org

Dec 20 2019

19mins

Play

Rank #8: Insights from Deal Trends: Betting on Tumor Immunology

Podcast cover
Read more
In this podcast from the 2019 Immuno-Oncology 360° conference, Cello Health BioConsulting's EVP, Oncology Practice Head, Dr Jeff Bockman discusses deal-making and investments in the I-O space to see what can be learned about the expanding and shifting landscape of BioPharma and investor interest by examining who is placing what kinds of bets on which targets and modalities, at what stage and with what terms.

Additional topics include:
Where are the next big paradigm shifts going to be?Where is the next great target that will supersize foundational checkpoint therapy?
Join us for the 6th annual IO360° conference on February 26-28, 2020 at the Crowne Plaza Times Square hotel in New York City.

To learn more about the event, please visit IO360 2020.

Aug 29 2019

22mins

Play

Rank #9: 2020 Immuno-Oncology 360° Summit Overview in 10 Minutes

Podcast cover
Read more
In this 10 minute podcast, Kate Woda, Conference Director for IO360°, walks you through what to expect at 2020 IO360° Summit happening February 26-28, 2020 in New York City. IO360°convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

The 6th annual IO360° Summit features the following plenaries:
Discovery/Preclinical ScienceImaging AspectsClinical OperationsBispecificsBusiness DevelopmentsCell & Gene TherapyTranslational ScienceEmerging BiomarkersIO Novel TechnologiesAI & Machine LearningClinical Developments
Keynotes:
Dr Carl June, University of PennsylvaniaDr Arie Belldegrun, AllogeneDr Andrew Baum, CitiDr Crystal Mackall, Stanford University School of Medicine
Learn more at www.io360summit.com

Dec 04 2019

11mins

Play

Rank #10: What are the Regulatory and Ethical Concerns of Integrating Care and Research?

Podcast cover
Read more
In this discussion, CRAACO co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, and Alison Bateman-House, PhD, MPH, MA, Assistant Professor Division of Medical Ethics, NYU Langone Health, consider what lines are being drawn in the integration of clinical care and clinical research. More specifically:
Research and care or treatment are separate spheres in the regulatory and ethical worlds. What happens when they are brought together?Are there ethical barriers that need to be overcome to allow clinical research to be offered as an option as part of clinical care?What are the ethical issues that surround offering a patient the opportunity to consider enrolling in a clinical trial?What current efforts are underway to address these issues?
This session was presented at the Clinical Research as a Care Option (CRAACO) meeting in April 2018 in Cambridge, MA.

The 2019 CRAACO conference will take place April 29-30, 2019 in Raleigh-Durham, NA. Learn more here.

Feb 06 2019

35mins

Play

Rank #11: Cell & Gene Therapy Day Overview in 4 minutes

Podcast cover
Read more
In this podcast, Kate Woda, Conference Director provides an overview of Cell & Gene Therapy Day in less than 4 minutes. Cell & Gene Therapy Day takes place on February 27, 2020 in New York City and convenes stakeholders spanning the science and business communities to report on the latest cell and gene therapy progress to fight a wider range of cancers beyond hematologic malignancies.

Key Topic Areas: 
Landscape and Evolution to Marketplace: ProgressNew Scientific Frontiers in Cell Therapies for Solid TumorsCell Therapy Pivotal Developments for Solid TumorsCurrent and Future Innovations Toward GMP Manufacturing of CAR and TCR Engineered T CellsFDA Led Session on the Evolution of Regulatory Policy for Cell & Gene Therapy
Cell & Gene Therapy Day is available as an independent one day program with a luncheon and networking reception, to learn more please visit theconferenceforum.org

Alternatively, attendees can register for the three day IO360° program, which includes Cell & Gene Therapy Day. For more information on IO360°, please visit www.io360summit.com

Dec 04 2019

4mins

Play

Rank #12: Translating Patient Insight and Patient Experience Internally into Deliverables

Podcast cover
Read more
Mary Stober Murray, Associate Director, Diversity and Patient Engagement for BMS, discusses applying quality systems framework (structure, processes, outcomes) to patient engagement initiatives to help create clinical development deliverables that meet industry goals while aligning with patients needs.
Mary Stober Murry will be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia to lead a roundtable discussion on Building Patient Engagement into Systematic Processes. Patients as Partners US is the only conference that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.  For more information visit www.theconferenceforum.org.

Jan 24 2019

37mins

Play

Rank #13: How to Innovate in the Drug Delivery Space

Podcast cover
Read more
How to Innovate in the Drug Delivery Space
What does the innovation process look likeThe barrier to the innovation process and how to overcomethemSummary of disease spaceGood design and engineering practicesHow to salvage something that goes wrong?How do you find the unknown unknowns?Does it feel right?
Uri Baruch

Head of Drug Delivery, Cambridge Design Partnership

This talk was given at the 2018 Drug Delivery West Meeting.

Jun 23 2018

32mins

Play

Rank #14: Patients as Partners in Clinical Research EU 5 Min Upcoming Conf Summary

Podcast cover
Read more
This 5 minute podcast summary helps prepare listeners on what they can expect at the4th Annual Patients as Partners Europe event, taking place January 27th and 28th in London. The venue is the Millennium Gloucester Hotel.

In a nutshell, Patient as Partners is the first conference in Europe dedicated to understanding how working with patients can drive greater clinical trial efficiencies throughout the entire medicines development process. It is ultimately about how to reduce risk in the development of hugely, costly clinical trials through working with patients. It is a wonderful opportunity for pharma and biotech and patient disease advocacy groups to come together and learn from each other. 

The 2020 Summit is chaired by Claire Nolan, of Charities Research Involvement Group, GSK’s Andrew Garvey and Parexel’s Rosamund Round. 

Our patient keynote guest is Lesley Gosden. Lesley is a Parkinson’s patient and advocate who participated in the GDNF clinical trial, which was featured on the BBC. For more information, visit the conferenceforum.org.

Jan 06 2020

7mins

Play

Rank #15: Clinical update on AMG 420, an anti-BCMA BiTE®

Podcast cover
Read more
In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE®

This talk addresses the:
Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy)
Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

Nov 01 2019

24mins

Play

Rank #16: How do Patients Become Partners in the Sharing of Data to Advance Science?

Podcast cover
Read more
In this podcast, hear a session from the 2019 Patients as Partners EU conference on How do Patients Become Partners in the Sharing of Data to Advance Science?
How to encourage the sharing of suitably anonymized data to further medicines development for the benefit of patients?What are the barriers/issues? Public mistrust of pharma? Language, medical records versus coded data?
Speakers:

Natalie Banner, PhD, Understanding Patient Data Lead, Wellcome Trust

Richard Stephens, Patient/Consumer Lead, Chair Consumer Forum, NCRI
The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.

Nov 06 2019

23mins

Play

Rank #17: Pfizer’s Atopic Dermatitis Clinical Trial with Digital Wearable Technology

Podcast cover
Read more
In this podcast from Mobile in Clinical Trials 2018, Pfizer's Project Team Lead, Early Clinical Development, Digital Medicine, Dr Carrie Northcott speaks about considerations and lessons learned from the validation, verification and use of digital wearable technology in a Atopic Dermatitis Clinical Trial and some of Pfizer's forward-leaning work in decision making around novel digital endpoints. 

Dr Northcott is coming back to Mobile 2019 to share results and next steps on this trial. 

Speakers: Carrie Northcott, PhD, Project Team Lead, Early Clinical Development, Digital Medicine, Pfizer, Inc

Aug 08 2019

23mins

Play

Rank #18: How Digital Biomarker Innovation is Modernizing Clinical Endpoints

Podcast cover
Read more
In this session from DPharm 2018, Roche provides an update on the company's progress in how they are collecting data with sensor technology and turning it into a clinically meaningful endpoint with multiple indications, including Parkinson's disease and Multiple Sclerosis. Session takeaways include:
Understand what Digital Biomarker innovation means for the future of clinical development and potentially personalized healthcare.Be inspired to use mobile sensors technology in the context of clinical trials and beyond.Develop a detailed understanding of the underlying complexity to run such efforts and be able to plan for it.Understand how regulators are looking at these novel approaches.
Speaker:

Christian Gossens, PhD, MBA, Global Head Early Development Workflows, pRED, Informatics, Roche Pharmaceutical Research and Early Development (pRED)

The 9th annual DPharm conference with take place on September 17-18, 2019 in Boston, MA. Learn more at theconferenceforum.org.

Jul 31 2019

17mins

Play

Rank #19: Merck’s Digital Health and Al Strategy: Progress Report

Podcast cover
Read more
In this session presented at the Mobile in Clinical Trials 2018 conference, Merck's Kai Bode and Jyoti Shah share an exciting update on the company's progress in implementing a digital health and AI strategy. Session takeaways include:
What Merck is doing in digital health and AIExternal collaborations on AISmart trial initiative to enable patient-centric studies
Kai Bode is returning to Mobile 2019 to share an update on Merck's digital strategy 2.0 and how they are engineering for scale.

Speakers: Jyoti Shah, Associate Director, Data Development MRL IT, Merck & Co, Inc

                   Kai Bode, Director, Digital and Analytics Technology, Merck & Co, Inc

Aug 07 2019

15mins

Play

Rank #20: How GSK Implemented Pivotal End-to-End Engagement Initiatives at Different Stage

Podcast cover
Read more
Dr Marilyn Metcalf, Head of the Center of Innovation for GSK, at the 5th annual Patients as Partners 2018 program. Dr Metcalf shares how GSK implemented pivotal end-to-end engagement initiatives at different stages of development. Dr Metcalf walked the audience through some examples of the engagement initiatives supported by:

• Creation of a framework and toolkit that builds on existing infrastructure

• Networks of champions and project leads

• Project planning

• Emerging best practices being shared throughout the organization
Dr Metcalf will also be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia where she leads a panel with patients and advocacy on Mapping Out the Patient Decision Making Journey. Patients as Partners US is the only conference that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. For more information visit www.theconferenceforum.org.

Jan 14 2019

15mins

Play

New Opportunities for Cell Therapy Combinations

Podcast cover
Read more
In this podcast moderated by Dr Michael Kalos, Janssen Oncology, you will hear a panel discussion from the 2019 IO Combinations 360° conference. Topic points include:
What are the new opportunities in cell therapy for combinations?What the challenges are going to be with the microenvironment?What is being done to engineer cell therapy?How do you develop CARs and TCRs that deliver payloads?How do you manufacture all of this beyond mouse models to

figure out how to effectively do this in patients?How do you actually go about designing trials and testing

hypothesis?How do you create the regulatory framework to do these types

of studies?How do you engage with regulatory agencies to get these things

moving?
Panelists include:
Sharon Benzeno, PhD, MBA, Adaptive BiotechnologiesChaohong Fan, MD, PhD, FDABruce Levine, PhD, University of PennsylvaniaMark Stewart, PhD, Friends of Cancer ResearchBahram Valamehr, PhD, Fate Therapeutics
To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Mar 10 2020

46mins

Play

PD1 Resistance with a Multi-Omic Approach

Podcast cover
Read more
Anti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address:
Orthogonality and correlation of response biomarkers across histologiesIntegration of multi-omic data sets for mechanistic insights into tumor immunobiologyThe translational approaches to PD1 resistance program at the Parker Institute
To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Mar 10 2020

25mins

Play

Updates on PARP Inhibition

Podcast cover
Read more
In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Darren Hodgson, AstraZeneca presented updates on PARP inhibition. Topics include:
Strategies to target homologous recombination repair deficiencyMonotherapy indications and current development landscapeScientific hypotheses being explored in olaparib combinations
To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Mar 09 2020

26mins

Play

Leveraging the Tumor Microenvironment for IO Therapy

Podcast cover
Read more
First recorded at the 4th annual IO Combinations 360° conference, this talk provided by Dr Kenneth Hance, GSK addresses agonistic strategies, T and NK cell redirection and the use of genetic/phenotypic assocations to identify novel target space in IO.

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Mar 08 2020

19mins

Play

Updates on Bintrafusp alfa/M7824 Clinical Data

Podcast cover
Read more
In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Laureen Ojalvo, EMD Serono provides an overview of the moleculte Bintrafusp alfa/M7824. This molecule is an innovative, first-in-class bifunctional fusion protein composed of an anti-PD-L1 mAb fused with 2 extracellular domains of TGF-βRII (a TGF-β “trap”). The mechanism of action, pre-clinical and phase 1 studies of this molecule is discussed as well as an overview of the next wave of clinical development.

To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Mar 07 2020

24mins

Play

NKTR-214: Harnessing the IL-2 Pathway in Combination Immunotherapies

Podcast cover
Read more
In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Willem Overwijk, Nektar Therapeutics discusses Bempegaldesleukin (NKTR-214): harnessing the IL-2 pathway in combination immunotherapies. Topics include:
Bempegaldesleukin: Structure and function of an engineered IL-2 cytokine prodrug providing sustained IL-2Rβγ-biased signalingPreclinical PK, PD, MOA and combination with PD-1 checkpoint inhibitionClinical PK, PD, clinical response data and biomarkers in patients with melanoma and bladder cancerCombinations under investigation
To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Mar 06 2020

20mins

Play

Advancing Bispecifics for Combination Immunotherapy

Podcast cover
Read more
First recorded at the fourth annual IO Combinations 360° conference, this panel moderated by Dr Daniel Chen, IGM Biosciences discusses advancing bispecifics for combination immunotherapy. This discussion covers the following topics:
What are the types of bispecifics and what are the limitations?What are the toxicity related side effects?What are teh next steps/levels for bispecifics?What does the future hold for bispecifics?
Panelists include:
Julie Bailis, PhD, AmgenRajkumar Ganesan, PhD, Janssen Research & DevelopmentDavid Schaer, PhD, Pfizer
To learn more about the 5th annual IO Combinations 360° conference please visit www.iocombinations360.com

Mar 02 2020

43mins

Play

How AI, Machine Learning and Big Data are Used to Inform Combinations

Podcast cover
Read more
In this podcast, you will hear a panel discussion from the 2019 IO Combinations 360° conference regarding how AI, machine learning and big data are used to inform combinations.

Moderated by Matthew Albert, MD, PhD, Insitro

Panelists:

Edward Bowen, GSK

Ryan Fukushima, Tempus

Renée Deehan-Kenney, PhD, QuartzBio, part of Precision for Medicine

To learn more about the 2020 IO Combinations 360° conference please visit www.iocombinations360.com

Mar 01 2020

52mins

Play

Weighing Your Options in Considering Clinical Trials from a Patient Perspective

Podcast cover
Read more
In this podcast, you will hear a panel discussion from the 2019 Clinical Research as a Care Option (CRAACO) conference with patients and advocates on weighing your care options and considering participation in a clinical trial. Some points include,
Strategies and ideas to reduce the burden to patientsUnderstanding of clinical care with their physician?Communication, consent and data sharing
Moderated by Cindy Geoghegan, Cancer Veteran, Patient Advocate

Panelists:

Allison Greiner Patient Advocate

Sarah Larson, Director of Global Clinical Operations, Biogen and Cancer Veteran

Kelly Piacsek, PhD, VP, Patient-Centered Research, Aurora Research Institute

The 2020 CRAACO conference will take place on April 27-28 in Raleigh, NC. Learn more here.

Feb 20 2020

32mins

Play

Understanding the Goals of Care vs Research

Podcast cover
Read more
In this podcast, you will hear a panel discussion from the 2019 Clinical Research as a Care Option (CRAACO) conference on Understanding the Goals of Care Vs Research. The panelists explore points including,
Goals for care vs goals for researchOversight and governanceIs there an ethical burden of breaking down the line between research and care?What is the hesitation behind embracing the blurring of this boundary?In areas like precision medicine, this is already blurring, how to manage?Hurdles stopping large companies from thinking about this– Is it practical? Ethical?
Moderated by Jennifer Byrne, CEO and Founder, Javara

Panelists:

Greg Burke, MD, MSc, Chief Science Officer, Senior Associate Dean for Research, Wake Forest School of Medicine

Amy Nordo, Director eSource Implementation, Pfizer

The 2020 CRAACO conference will take place on April 27-28 in Raleigh, NC. Learn more here.

Feb 19 2020

28mins

Play

7th Annual Patients as Partners US: What to Expect in 5 Minutes

Podcast cover
Read more
This 5 minute podcast summarizes what you can expect at the Patients as Partners US conference. This is the only event in R&D that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.

The 7th annual Patients as Partners US program features the following key topic areas:
BioPharma Strategies on Applying Patient Engagement Initiatives and Demonstrating ImpactDirect-to-Patient Clinical Trials Next Milestones and Actions to Get ThereMeasuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentCurrent Efforts for Educating and Enrolling Diverse Populations in Clinical TrialsProgress on Patient Data OwnershipCollaborating with Site Partners & CROs to Increase Efficiencies, Provide Greater Value to Patients and Clinical TrialsProgress on the National Health Council’s Patient Engagement Fair Market Value InitiativeFDA Reports on the Latest Guidance Updates and New Agency Efforts on Patient Engagement
Keynotes include:
Jeff Borghoff, Alzheimer's Patient and AdvocateChip Bell, Customer Service GuruDr Joanne Waldstreicher, Johnson & JohnsonDr Darryl Sleep, AmgenKen Getz, CISCRP/Tufts CSDD
Patients as Partners US takes place June 29-30, 2020 at the Hilton Philadelphia at Penn's Landing, Philadelphia, PA. For more information please visit www.patientsaspartners.org

Feb 18 2020

5mins

Play

How to Integrate Industry Sponsored Clinical Trials Into Your Health System

Podcast cover
Read more
In this podcast, you will hear a session from the 2019 Clinical Research as a Care Option (CRAACO) conference on How to Integrate Industry-Sponsored Clinical Trials Into Your Health System to Give Patients the Best Options. Points include,
How to build your programsHow to become an integrated care & research organizationHow to integrate clinical research into your care systemRoswell Park and TrialScout’s strategic partnership
Speakers:

Irfan Khan, MD, CEO and Founder, Circuit Clinical

Doug Plessinger, Chief Clinical & Scientific Development Officer, Roswell Park/GBCT

The 2020 CRAACO conference will take place on April 27-28 in Raleigh, NC. Learn more here.

Feb 18 2020

23mins

Play

How Sanford Health Systems Increased Clinical Trial Participation to 10%

Podcast cover
Read more
In this podcast, you will hear a case study presentation from the 2019 Clinical Research as a Care Option (CRAACO) conference on how Sanford Health Systems has increased their clinical trial participation from 3% to 10% over the last 8 years by integrating clinical care and clinical research. Points include,
Creating a system for all providers to work seamlesslyEducational programs and continual training across all areas of care and specialties for trial offeringsIdentifying gaps in trial availabilityAttracting providers who are interested in clinical research for their patientsNCORP site
The 2020 CRAACO conference will take place on April 27-28 in Raleigh, NC. Learn more here.

Feb 17 2020

28mins

Play

Keynote: Surgeon’s Perspective on Integrating Clinical Care & Clinical Research

Podcast cover
Read more
In this podcast, you will hear a keynote presentation from the 2019 Clinical Research as a Care Option (CRAACO) conference. Dr Laura Esserman, the architect behind the I-SPY 2 TRIALTM has achieved remarkable progress with this clinical trial in improving the outcomes of early stage, breast cancer for patients who are at high risk for early recurrence. I-SPY 2 is also impacting far beyond breast cancer by increasing efficiencies that promise to accelerate the development and delivery of more effective therapies for other cancer types and a range of other diseases. This would not be possible without the integration of care and research. In this keynote session, hear this surgeon’s view on the future of integrating care and research.

Speaker:

Laura Esserman, MD, MBA, Director, UCSF Carol Franc Buck Breast Cancer Center; Alfred A. de Lorimier Endowed Chair in General Surgery; Professor of Surgery and Radiology, UCSF

The 2020 CRAACO conference will be taking place April 27-28 in Raleigh, NC. Learn more about it here.

Feb 14 2020

40mins

Play

How Wilmington Health is Streamlining Integration of Clinical Research & Care

Podcast cover
Read more
In this podcast, you will hear a session from the 2019 Clinical Research as a Care Option (CRAACO) conference. Jeff James, CEO of Wilmington Health, presented a case study on how they are streamlining the processes behind integrating clinical care and clinical research, including:
Going from a fragmented patient journey to a streamlined oneHow to take the patient experience to “just making it another visit type”How to take study protocols and make them more native to EMRGeneral best practices for streamlining the process for patients and investigatorsWhat it took to actively normalize the flows and processes of clinical research
The 2020 CRAACO conference will take place on April 27-28 in Raleigh, NC. Learn more here.

Feb 13 2020

31mins

Play

Addressing Barriers Health Systems Face in Integrating Clinical Care & Research

Podcast cover
Read more
At the 2019 Clinical Research as a Care Option (CRAACO) conference, a panel discussed Barriers Health Systems Face in Integrating Clinical Care & Research, including:
Financial barriers – Speaking to administration’s bottom lineHistorical barriers – Who are the key stakeholders that need to be converted into believers of the CRAACO movement?Logistical issues – How can we make study startup a more streamlined process?Culture change – Onboarding an outside group nested into an existing infrastructureDoes adding the offering of clinical trials disrupt the ability of the physicians in the clinics to have appropriate patient flow?How do you offer patients the options of clinical research?Insight from the front line of physicians seeing patients
Moderated by: Lora Black, Senior Director of Clinical Research, Sanford Health Systems

Panelists: 

Greg Burke, MD, MSc, Chief Science Officer, Senior Associate Dean for Research, Wake Forest School of Medicine

Adrian Hernandez, MD, MHS, Vice Dean for Clinical Research, Duke University School of Medicine

The 2020 CRAACO conference will be taking place July 13-14, 2020 in Raleigh, NC. Learn more here.

Feb 12 2020

25mins

Play

Effectively Democratizing Access to Clinical Trials for All

Podcast cover
Read more
In this podcast, you will hear a discussion from the 2019 Clinical Research as a Care Option (CRAACO) conference on Effectively Democratizing Access to Clinical Trials. This panel covers how making clinical research a care option is the ultimate opening of access to clinical trials. Including points on:
Current state of affairs: Gross underrepresentation of minorities 5-6% are represented in trials, but it should be closer to 40%What are the barriers to opening access?How can we educate underserved communities about clinical research?What are we doing to overcome this?Does offering these care options enhance access in a broad sense?
Moderated by:

Jennifer Sheller, MPH, Regional Head, North America, Merck

Panelists:

Jonathan Jackson, PhD, Director, CARE Research Center, Massachusetts General Hospital

Cynthia Verst, PharmD, President, Design and Delivery Innovation, IQVIA

The 2020 CRAACO conference will take place on July 13-14, 2020 in Raleigh, NC. Learn more here.

Feb 11 2020

28mins

Play

Delivering an Innovative, Patient-Centric Delivery System

Podcast cover
Read more
A new way of doing business was required to achieve the mission of serving patients suffering from rheumatoid arthritis. In this podcast, first recorded at the 2nd annual Drug Delivery West conference, William (Bill) Rich, Amgen and Daniele Fazio, Flex discuss how Amgen and Flex created an integrated, single team with co-executive sponsorship and overarching program management that enabled the successful development and launch of a novel combination product.

To learn more about the 3rd annual Drug Delivery West conference happening May 17-18, 2021 in San Francisco, CA please visit www.drugdeliverywest.org

Feb 06 2020

22mins

Play

Ophthalmology: Exploring Other Routes of Administration

Podcast cover
Read more
In this podcast, first recorded at the 2nd annual Drug Delivery West conference, Dr James Cunningham, Allergan leads a panel on exploring other routes of administration for ophthalmology. Discussion points include:
Barries/challenges associated with drug delivery to the back of the eyeProlonging delivery & reducing frequency of administrationAlternative/less invasive routes of administration for delivery to the back of the eyeDelivery for emerging modalitiesImpact of delivery system design choices on development/scalabilityHow to effectively assess novel delivery approaches
Panelists include:
Dr James E Chastain, Novartis Institutes for BioMedical Research, IncDr Susan Crowell, GenentechDr Viral Kansara, Clearside Bio
To learn more about the 3rd annual Drug Delivery West conference happening May 17-18, 2021 in San Francisco, CA please visit www.drugdeliverywest.org

Feb 06 2020

43mins

Play

Transforming Cardiovascular Treatment with Pulmonary Delivery

Podcast cover
Read more
First recorded at the 2nd annual Drug Delivery West conference, Dr Carlos Schuler, InCarda Therapeutics discusses transforming cardiovascular treatment with pulmonary delivery. This podcast discusses:
Pioneering a novel approach for treating cardiovascular conditions by the oral inhalation routeWill be the ONLY non-invasive, self administered product for acute management of Paroxysmal Atrial Fibrilation, providing rapid cardioversionIn Phase 2: Dose dependent conversion observedWorking on enhancements to greatly improve speed of delivery
To learn more about the 3rd annual Drug Delivery West conference happening May 17-18, 2021 in San Francisco, CA please visit www.drugdeliverywest.org

Feb 05 2020

16mins

Play

iTunes Ratings

11 Ratings
Average Ratings
8
3
0
0
0